Apremilast for the treatment of Behcet's syndrome

Hatemi G., Yazici Y.

EXPERT OPINION ON ORPHAN DRUGS, vol.5, no.8, pp.677-681, 2017 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 5 Issue: 8
  • Publication Date: 2017
  • Doi Number: 10.1080/21678707.2017.1356716
  • Journal Name: EXPERT OPINION ON ORPHAN DRUGS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.677-681
  • Istanbul University Affiliated: Yes

Abstract

Introduction: Mucocutaneous lesions can be disabling in Behcet's syndrome patients who experience these lesions frequently and can be an important cause of impaired quality of life. Apremilast may be a safe and effective alternative for the treatment of oral and genital ulcers in Behcet's syndrome.